The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products ...
Biosimilars marketed in the US typically have list prices 15% to 35% lower than ... if needed – at mealtimes for example – with fast-acting insulins. The cost of insulin products has become ...
List prices for drugs often differ from what ... Both Humalog and Insulin Lispro Injection are fast-acting insulins, they are used to control high blood sugar in adults and children with diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results